MedPath
FDA Approval

Docetaxel

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 4, 2023
Labeling Type
Human Prescription Drug Label
Docetaxel(10 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Inc.

675480402

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Docetaxel

Product Details

NDC Product Code
62332-678
Application Number
ANDA215744
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
September 4, 2023
DocetaxelActive
Code: 699121PHCAClass: ACTIBQuantity: 10 mg in 1 mL
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQClass: IACT

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

BOXED WARNING SECTION

**WARNING: TOXIC DEATHS, HEPATOTOXICITY, NEUTROPENIA, HYPERSENSITIVITY

REACTIONS, and FLUID RETENTION**


© Copyright 2025. All Rights Reserved by MedPath
Docetaxel - FDA Approval | MedPath